PROBUPHINE



Trademark Coverage

No Class Specified

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Owner

Titan Pharmaceuticals, Inc.

Business in South San Francisco, CA

Owns 31 trademarks

Timeline
  • Dec 19
    2013
    Review Of Correspondence Complete Power Of Attorney Entered
  • Dec 12
    2013
    TEAS Withdrawal Of Attorney Received Firm Retains
  • Feb 21
    2012
    Registered Principal Register
  • Jan 14
    2012
    Notice Of Acceptance Of Statement Of Use Mailed
  • Jan 13
    2012
    Law Office Registration Review Completed
  • Jan 13
    2012
    Allowed Principal Register SOU Accepted
  • Jan 04
    2012
    Statement Of Use Processing Complete
  • Dec 09
    2011
    Use Amendment Filed
  • Dec 30
    2011
    Case Assigned To Intent To Use Paralegal
  • Dec 09
    2011
    TEAS Statement Of Use Received
  • Jul 05
    2011
    NOA Mailed SOU Required From Applicant
  • May 10
    2011
    Published For Opposition
  • Apr 20
    2011
    Notice Of Publication
  • Apr 02
    2011
    Law Office Publication Review Completed
  • Apr 02
    2011
    Assigned To LIE
  • Mar 18
    2011
    Approved For PUB Principal Register
  • Mar 04
    2011
    TEAS/Email Correspondence Entered
  • Mar 03
    2011
    Correspondence Received In Law Office
  • Mar 03
    2011
    TEAS Response To Office Action Received
  • Dec 08
    2010
    Non Final Action Mailed
  • Dec 08
    2010
    Non Final Action Written
  • Dec 03
    2010
    Assigned To Examiner
  • Aug 24
    2010
    New Application Office Supplied Data Entered In TRAM
  • Aug 21
    2010
    New Application Entered In TRAM